Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Cipla
Moodys
Julphar
Medtronic
Accenture
Queensland Health
Teva
Healthtrust

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017963

« Back to Dashboard

NDA 017963 describes LOPRESSOR, which is a drug marketed by Novartis and Us Pharms Holdings I and is included in four NDAs. It is available from three suppliers. Additional details are available on the LOPRESSOR profile page.

The generic ingredient in LOPRESSOR is hydrochlorothiazide; metoprolol tartrate. There are thirty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.
Summary for 017963
Tradename:LOPRESSOR
Applicant:Us Pharms Holdings I
Ingredient:metoprolol tartrate
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 017963
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 017963
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LOPRESSOR metoprolol tartrate TABLET;ORAL 017963 NDA Medi-Physics Inc. 17156-601 N 17156-601-51
LOPRESSOR metoprolol tartrate TABLET;ORAL 017963 NDA Medi-Physics Inc. 17156-602 N 17156-602-52

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 017963

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Us Pharms Holdings I LOPRESSOR metoprolol tartrate TABLET;ORAL 017963-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Fuji
US Army
Covington
Chubb
McKinsey
Accenture
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot